[Premature immune senescence and chronic kidney disease: Update and perspectives].
Fiche publication
Date publication
décembre 2019
Journal
Nephrologie & therapeutique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr DUCLOUX Didier, Mme LAHEURTE Caroline
Tous les auteurs :
Crépin T, Legendre M, Courivaud C, Vauchy C, Laheurte C, Rebibou JM, Saas P, Ducloux D, Bamoulid J
Lien Pubmed
Résumé
Immune senescence is associated with age-related diseases (i.e. infectious disease, cardiovascular diseases and cancers). Chronic kidney disease patients die prematurely when compared with general population, because of a higher occurrence of infections, cardiovascular events and cancer. These diseases are commonly observed in the elderly population and frequently associated with immune senescence. Indeed, chronic kidney disease causes a premature aging of the T lymphocyte compartment, widely related to a decrease in thymic function, a phenomenon that plays a key role in the onset of age-related diseases in chronic kidney disease patients. The degree of immune senescence also influences patients' outcome after renal transplantation, particularly the risk of acute rejection and infections. Partial reversion of pre-transplant immune senescence is observed for some renal transplant patients. In conclusion, to reduce the increasing incidence of morbidity and mortality of chronic kidney disease patients, a better knowledge of uremia-induced immune senescence would help to pave the way to build clinical studies and promote innovative therapeutic approaches. We believe that therapeutic reversion and immune senescence prevention approaches will be part of the management of chronic kidney disease patients in the future.
Mots clés
Chronic kidney disease, Dialyse, Dialysis, Fonction thymique, Immune senescence, Immunosénescence, Infection, Infectious disease, Insuffisance rénale chronique, Thymus gland, Transplantation
Référence
Nephrol. Ther.. 2019 Dec 14;: